Search research articles
Contact Us
Filters
Showing results (131-140 of 263) with videos related to
Page
of 27
Sort By:
Journal of Chemical Information and Modeling
|
October 30, 2019
Correction to "admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties"
Feixiong Cheng, Weihua Li, Yadi Zhou, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
June 4, 2025
Alzheimer's disease drug development pipeline: 2025
Jeffrey L Cummings, Yadi Zhou, Garam Lee, et al.
Plos One
|
March 24, 2012
Investigation of indazole unbinding pathways in CYP2E1 by molecular dynamics simulations
Zhonghua Shen, Feixiong Cheng, You Xu, et al.
Frontiers in Pharmacology
|
July 12, 2021
Systemic Administration of Tempol Attenuates the Cardiorespiratory Depressant Effects of Fentanyl
Santhosh Baby, Ryan Gruber, Joseph Discala, et al.
NPJ Digital Medicine
|
November 7, 2022
Multimodal machine learning in precision health: A scoping review
Adrienne Kline, Hanyin Wang, Yikuan Li, et al.
Plos Computational Biology
|
May 17, 2012
Prediction of drug-target interactions and drug repositioning via network-based inference
Feixiong Cheng, Chuang Liu, Jing Jiang, et al.
Plos Computational Biology
|
February 27, 2020
Individualized genetic network analysis reveals new therapeutic vulnerabilities in 6,700 cancer genomes
Chuang Liu, Junfei Zhao, Weiqiang Lu, et al.
JCI Insight
|
June 8, 2018
Repurposing sertraline sensitizes non-small cell lung cancer cells to erlotinib by inducing autophagy
Xingwu Jiang, Weiqiang Lu, Xiaoyang Shen, et al.
Medicinal Research Reviews
|
July 14, 2020
Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing
Jiansong Fang, Andrew A Pieper, Ruth Nussinov, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
October 18, 2022
The Alzheimer's Cell Atlas (TACA): A single-cell molecular map for translational therapeutics accelerator in Alzheimer's disease
Yadi Zhou, Jielin Xu, Yuan Hou, et al.
Page
of 27
Search research articles
Search
Showing results (131-140 of 263) with videos related to
Sort By:
Page
of 27
Journal of Chemical Information and Modeling
|
October 30, 2019
Correction to "admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties"
Feixiong Cheng, Weihua Li, Yadi Zhou, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
June 4, 2025
Alzheimer's disease drug development pipeline: 2025
Jeffrey L Cummings, Yadi Zhou, Garam Lee, et al.
Plos One
|
March 24, 2012
Investigation of indazole unbinding pathways in CYP2E1 by molecular dynamics simulations
Zhonghua Shen, Feixiong Cheng, You Xu, et al.
Frontiers in Pharmacology
|
July 12, 2021
Systemic Administration of Tempol Attenuates the Cardiorespiratory Depressant Effects of Fentanyl
Santhosh Baby, Ryan Gruber, Joseph Discala, et al.
NPJ Digital Medicine
|
November 7, 2022
Multimodal machine learning in precision health: A scoping review
Adrienne Kline, Hanyin Wang, Yikuan Li, et al.
Plos Computational Biology
|
May 17, 2012
Prediction of drug-target interactions and drug repositioning via network-based inference
Feixiong Cheng, Chuang Liu, Jing Jiang, et al.
Plos Computational Biology
|
February 27, 2020
Individualized genetic network analysis reveals new therapeutic vulnerabilities in 6,700 cancer genomes
Chuang Liu, Junfei Zhao, Weiqiang Lu, et al.
JCI Insight
|
June 8, 2018
Repurposing sertraline sensitizes non-small cell lung cancer cells to erlotinib by inducing autophagy
Xingwu Jiang, Weiqiang Lu, Xiaoyang Shen, et al.
Medicinal Research Reviews
|
July 14, 2020
Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing
Jiansong Fang, Andrew A Pieper, Ruth Nussinov, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
October 18, 2022
The Alzheimer's Cell Atlas (TACA): A single-cell molecular map for translational therapeutics accelerator in Alzheimer's disease
Yadi Zhou, Jielin Xu, Yuan Hou, et al.
Page
of 27